Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Regenerating the lost pancreatic β-cells in TIDM patients: G-CSF (Granulocyte colony-stimulating factor) increases insulin-secreting cell mass and function via up regulation of its target genes, 14/June/2015, 12.00 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Given that (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) the life-long painful injection/drug treatment required to treat DM; and (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult β-cells that were lost in DM; (ii) a cheaper alternative to the existing expensive drugs; and (iii) a side-effect-free natural product-based drug.
This study suggests a GCSF-based Regenerative therapy for T1DM. GCSF, by increasing the expression of its target gene, it may increase insulin-secreting cell mass and function. Thereby, it may increase insulin sensitivity of cellular tissues. Thus, pharmacological formulations encompassing “GCSF or its activators” can be used to treat TIDM.
Undisclosed information: How GCSF increases insulin-secreting cell mass and function.
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation